{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T02:11:05Z","timestamp":1766974265336,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,28]]},"DOI":"10.7759\/cureus.100278","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T02:07:06Z","timestamp":1766974026000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Tumor-Infiltrating Immune Cells and Early Recurrence in Ampulla of Vater Carcinoma"],"prefix":"10.7759","author":[{"given":"Kyohei","family":"Yoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Soyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-006-0213-3","article-title":"Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection","volume":"31","author":"Qiao QL","year":"2007","unstructured":"Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007, 31:137-43; discussion 144-6. 10.1007\/s00268-006-0213-3","journal-title":"World J Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(05)80197-7","article-title":"Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival","volume":"117","author":"Allema JH","year":"1995","unstructured":"Allema JH, Reinders ME, van Gulik TM, et al.. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery. 1995, 117:247-53. 10.1016\/s0039-6060(05)80197-7","journal-title":"Surgery"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21374","article-title":"Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program","volume":"100","author":"Albores-Saavedra J","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol. 2009, 100:598-605. 10.1002\/jso.21374","journal-title":"J Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen W","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin. 2016, 66:115-32. 10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244987","article-title":"Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database","volume":"16","author":"Feng J","year":"2021","unstructured":"Feng J, Wu R, Zhang G, Yang Z, Zhang L. Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database. PLoS One. 2021, 16:e0244987. 10.1371\/journal.pone.0244987","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"Kimura W","year":"1994","unstructured":"Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994, 85:161-6. 10.1111\/j.1349-7006.1994.tb02077.x","journal-title":"Jpn J Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2603-0","article-title":"Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?","volume":"20","author":"Westgaard A","year":"2013","unstructured":"Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?. Ann Surg Oncol. 2013, 20:430-9. 10.1245\/s10434-012-2603-0","journal-title":"Ann Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000112","article-title":"Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study","volume":"43","author":"Robert PE","year":"2014","unstructured":"Robert PE, Leux C, Ouaissi M, et al.. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study. Pancreas. 2014, 43:692-7. 10.1097\/MPA.0000000000000112","journal-title":"Pancreas"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.03.005","article-title":"Long-term outcomes after pancreatoduodenectomy for ampullary cancer: the influence of the histological subtypes and comparison with the other periampullary neoplasms","volume":"21","author":"Nappo G","year":"2021","unstructured":"Nappo G, Galvanin J, Gentile D, et al.. Long-term outcomes after pancreatoduodenectomy for ampullary cancer: the influence of the histological subtypes and comparison with the other periampullary neoplasms. Pancreatology. 2021, 21:950-6. 10.1016\/j.pan.2021.03.005","journal-title":"Pancreatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0529-5807.2019.02.003","article-title":"Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance [Article in Chinese]","volume":"48","author":"Liu FF","year":"2019","unstructured":"Liu FF, Shen DH, Wang HL, et al.. Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance [Article in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2019, 48:92-7. 10.3760\/cma.j.issn.0529-5807.2019.02.003","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31951","article-title":"Ampullary cancer: evaluation of somatic and germline genetic alterations and association with clinical outcomes","volume":"125","author":"Wong W","year":"2019","unstructured":"Wong W, Lowery MA, Berger MF, et al.. Ampullary cancer: evaluation of somatic and germline genetic alterations and association with clinical outcomes. Cancer. 2019, 125:1441-8. 10.1002\/cncr.31951","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25808","article-title":"Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma","volume":"121","author":"Al Abbas AI","year":"2020","unstructured":"Al Abbas AI, Falvello V, Zenati M, et al.. Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma. J Surg Oncol. 2020, 121:322-9. 10.1002\/jso.25808","journal-title":"J Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.02.008","article-title":"Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience","volume":"44","author":"Jin Z","year":"2018","unstructured":"Jin Z, Hartgers ML, Sanhueza CT, et al.. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. Eur J Surg Oncol. 2018, 44:677-83. 10.1016\/j.ejso.2018.02.008","journal-title":"Eur J Surg Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1156-4","article-title":"Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater","volume":"14","author":"de Paiva Haddad LB","year":"2010","unstructured":"de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2010, 14:719-28. 10.1007\/s11605-010-1156-4","journal-title":"J Gastrointest Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.799025","article-title":"Review of immunohistochemistry biomarkers in pancreatic cancer diagnosis","volume":"11","author":"Luu TT","year":"2021","unstructured":"Luu TT. Review of immunohistochemistry biomarkers in pancreatic cancer diagnosis. Front Oncol. 2021, 11:799025. 10.3389\/fonc.2021.799025","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122168","article-title":"Basis of PD1\/PD-L1 therapies","volume":"8","author":"Seliger B","year":"2019","unstructured":"Seliger B. Basis of PD1\/PD-L1 therapies. J Clin Med. 2019, 8:10.3390\/jcm8122168","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00082-2","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"25","author":"Burris HA 3rd","year":"2024","unstructured":"Burris HA 3rd, Okusaka T, Vogel A, et al.. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2024, 25:626-35. 10.1016\/S1470-2045(24)00082-2","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian YY","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, et al.. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021, 398:27-40. 10.1016\/S0140-6736(21)00797-2","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok JD","year":"2022","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al.. Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma. J Clin Oncol. 2022, 40:127-37. 10.1200\/JCO.21.02229","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8524-1","article-title":"Regulation of T cell responses by the receptor molecule Tim-3","volume":"59","author":"Gorman JV","year":"2014","unstructured":"Gorman JV, Colgan JD. Regulation of T cell responses by the receptor molecule Tim-3. Immunol Res. 2014, 59:56-65. 10.1007\/s12026-014-8524-1","journal-title":"Immunol Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin MA","year":"2007","unstructured":"Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007, 445:771-5. 10.1038\/nature05543","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2020.99.5.259","article-title":"Predictors of early recurrence following a curative resection in patients with a carcinoma of the ampulla of Vater","volume":"99","author":"Ma CH","year":"2020","unstructured":"Ma CH, Lee JH, Song KB, Hwang DW, Kim SC. Predictors of early recurrence following a curative resection in patients with a carcinoma of the ampulla of Vater. Ann Surg Treat Res. 2020, 99:259-67. 10.4174\/astr.2020.99.5.259","journal-title":"Ann Surg Treat Res"},{"key":"ref24","article-title":"TNM Classification of Malignant Tumours, 7th Edition","author":"Sobin LH","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th Edition. Wiley-Blackwell, Oxford; 2009."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer","volume":"105","author":"Kim WS","year":"2012","unstructured":"Kim WS, Choi DW, Choi SH, Heo JS, You DD, Lee HG. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. J Surg Oncol. 2012, 105:266-72. 10.1002\/jso.22090","journal-title":"J Surg Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin X","year":"2024","unstructured":"Lin X, Kang K, Chen P, et al.. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024, 23:108. 10.1186\/s12943-024-02023-w","journal-title":"Mol Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10605-y","article-title":"Efficacy of PD-1\/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis","volume":"23","author":"Huo G","year":"2023","unstructured":"Huo G, Liu W, Chen P. Efficacy of PD-1\/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis. BMC Cancer. 2023, 23:143. 10.1186\/s12885-023-10605-y","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01125-3","article-title":"Tumor immune microenvironment (TIME) to enhance antitumor immunity","volume":"28","author":"Rajbhandary S","year":"2023","unstructured":"Rajbhandary S, Dhakal H, Shrestha S. Tumor immune microenvironment (TIME) to enhance antitumor immunity. Eur J Med Res. 2023, 28:169. 10.1186\/s40001-023-01125-3","journal-title":"Eur J Med Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v12.i10.845","article-title":"Relationship between Th17 immune response and cancer","volume":"12","author":"Marques HS","year":"2021","unstructured":"Marques HS, de Brito BB, da Silva FA, et al.. Relationship between Th17 immune response and cancer. World J Clin Oncol. 2021, 12:845-67. 10.5306\/wjco.v12.i10.845","journal-title":"World J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo DG","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019, 19:369-82. 10.1038\/s41577-019-0127-6","journal-title":"Nat Rev Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03819-x","article-title":"Correction to: efficacy and safety of anti\u2011PD\u20111\/PD\u2011L1\u2011based dual immunotherapies versus PD\u20111\/PD\u2011L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta\u2011analysis","volume":"73","author":"Chen Y","year":"2024","unstructured":"Chen Y, Han H, Cheng J, et al.. Correction to: efficacy and safety of anti\u2011PD\u20111\/PD\u2011L1\u2011based dual immunotherapies versus PD\u20111\/PD\u2011L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta\u2011analysis. Cancer Immunol Immunother. 2024, 73:263. 10.1007\/s00262-024-03819-x","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417420-association-between-tumor-infiltrating-immune-cells-and-early-recurrence-in-ampulla-of-vater-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T02:07:08Z","timestamp":1766974028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417420-association-between-tumor-infiltrating-immune-cells-and-early-recurrence-in-ampulla-of-vater-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.100278","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}